Exodus Point Capital Management, LP Insmed Inc Transaction History

Exodus Point Capital Management, LP

$14.7 Billion
Q2 2024

A detailed history of Exodus Point Capital Management, LP transactions in Insmed Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 25,000 shares of INSM stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,000

Previous 25,000 -0.0%

Holding current value

$1.81 Million

Previous $680,000 145.88%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$22.0 - $69.71 $937,310 - $2.97 Million	42,605 New	42,605 $2.86 Million
Q3 2023 Nov 09, 2023	BUY	$19.86 - $26.93 $658,656 - $893,133	33,165 New	33,165 $837,000
Q4 2022 Feb 13, 2023	SELL	$16.98 - $23.15 $2.6 Million - $3.55 Million	-153,307 Reduced 67.08%	75,227 $1.5 Million
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $4.45 Million - $6.01 Million	213,093 Added 1380.05%	228,534 $4.92 Million
Q2 2022 Aug 19, 2022	BUY	$17.07 - $25.71 $263,577 - $396,988	15,441 New	15,441 $304,000
Q2 2021 Aug 16, 2021	SELL	$24.17 - $36.01 $1.62 Million - $2.41 Million	-67,008 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $119,113 - $163,467	3,690 Added 5.83%	67,008 $2.28 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $1.73 Million - $2.24 Million	55,132 Added 673.49%	63,318 $2.11 Million
Q3 2020 Nov 16, 2020	SELL	$26.0 - $34.5 $148,980 - $197,685	-5,730 Reduced 41.18%	8,186 $263,000
Q2 2020 Aug 14, 2020	BUY	$14.11 - $29.42 $196,354 - $409,408	13,916 New	13,916 $383,000
Q1 2020 May 15, 2020	SELL	$13.63 - $33.98 $328,101 - $817,966	-24,072 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $33,948 - $52,607	2,106 Added 9.59%	24,072 $575,000
Q3 2019 Nov 14, 2019	BUY	$15.49 - $25.78 $340,253 - $566,283	21,966 New	21,966 $387,000

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Insmed Inc Transaction History